How Finished-Product Magnesium Is Tested

• Reviewed by KS Nutripharma Director of R&D (PhD, Food Science
• 19+ years nutraceutical development)
• Technical review scope: incoming raw-material testing, finished-product release testing, identity versus assay, specification versus COA, multi-salt magnesium, and stability documentation

Introduction:

Finished-product magnesium is tested against the approved finished-product specification — not against the incoming drum COA. A raw-material certificate of analysis describes the salt that entered manufacturing. A finished-product COA reports what that manufactured batch tested at, on the sample and method named in the release file. Those documents are not interchangeable. A buyer who compares two OEM quotations using only the incoming assay is comparing starting material, not the released capsules, tablets, powder, or liquid. For salt choice and milligram architecture, see magnesium supplements. The testing question is narrower: what each result actually proves, and which documents make two quotes comparable.

Adult oral dietary supplements are the scope. Injections, bath salts, and children’s lines sit outside this comparison.

Raw-Material Testing vs Finished-Product Testing

Raw-material testing verifies the input. Finished-product testing verifies the manufactured product.

When a drum of magnesium citrate, magnesium bisglycinate, magnesium oxide, or another named salt arrives, the incoming COA answers whether that lot matches the purchased grade: identity, magnesium content on the stated basis, and the contaminant and physical fields on the raw-material specification. It does not verify blend uniformity, fill-weight consistency, material loss during processing, or the composition of the finished batch.

U.S. dietary-supplement GMP requires product specifications for identity, purity, strength, composition, and contamination limits, and requires those specifications to be verified on finished batches — on every finished batch, or on a subset identified through a sound statistical sampling plan.[1][2][3] Other markets use their own quality-system rules. The incoming file and the release file remain different commercial documents. What matters next is what each test proves, how the result is reported, and what a buyer should request before two magnesium quotes are treated as the same SKU.

What a Magnesium COA Actually Proves

A COA is a batch report. It records results obtained by named methods against named limits. It is not a catalog description, and it is not a substitute for the specification those limits came from.

On a magnesium project, the fields usually fall into four jobs:

Identity answers whether the material matches the declared magnesium salt or grade. A passing identity result supports “this is the named raw material.” It does not, by itself, state how much magnesium is present.

Assay answers how much of a defined analyte is present on a defined basis — often elemental magnesium, sometimes the compound, sometimes another magnesium-content basis written into the specification. A passing assay supports “this lot meets the strength line.” It does not, by itself, prove which salt carried that magnesium.

Contaminants — typically elemental impurities such as lead, arsenic, cadmium, and mercury, plus a microbiological panel — answer whether the lot meets the stated limits. Raw-material limits and finished-product limits are not automatically the same numbers, because the matrix, dilution, excipients, and destination-market file can differ.

Physical properties — particle size, bulk density, tap density, loss on drying or water content, appearance — answer whether the material will process as expected. For magnesium salts, those fields often decide encapsulation, compression, and powder filling more directly than the front-label milligram line.

Two COAs can both print “magnesium assay” and still not be comparable. The result is only as useful as the identity of the salt, the analytical basis, the reporting unit, and the specification it was judged against.

Identity and Assay Are Not the Same Test

A magnesium number alone does not establish the identity of the salt. A material can show an expected magnesium concentration without proving that it is the specific magnesium compound stated in the specification.

That split is the most common source of false confidence on magnesium files. Magnesium oxide, magnesium citrate, magnesium malate, magnesium glycinate / bisglycinate, and a buffered glycinate grade can all produce a magnesium assay. The assay does not tell the laboratory which of those materials was in the flask. Identity does.

Identity is a specification-dependent confirmation that the incoming grade is the declared raw material. Methods are chosen for that salt and that file — spectroscopic methods, chromatographic methods for a relevant ligand or organic anion, titration identity tests, or other scientifically valid procedures named on the specification. Chelates are not identified by a single default technique, and HPLC is not a universal proof that a material is magnesium bisglycinate. The governing method is the one on the approved specification, not a generic “magnesium test.”

Assay is a quantitative determination of magnesium content, or of another defined analyte, by the approved method. Titration, ICP-OES, ICP-MS, and atomic absorption are common magnesium-content techniques. They quantify magnesium in the sample prepared according to that method. They do not convert a citrate drum into a glycinate drum, and they do not disclose whether a glycinate grade is fully reacted or buffered.

A buffered material can assay at a magnesium level that looks commercially attractive and still be a different composition from a fully reacted chelate sold under the same front name. Composition is a specification and identity question. Elemental magnesium is an assay question. Treating the second as proof of the first is how two “glycinate 200 mg” quotes become incomparable without anyone noticing.

What Is Tested on the Finished Magnesium Product?

Finished-product testing is whatever the approved finished-product specification requires for that formula, dosage form, and destination market — plus the tests selected to verify that the production system is meeting those specifications.[2] It is not a fixed menu copied from a pharmaceutical dosage-unit monograph.

Finished-product magnesium assay verifies the magnesium content of the finished product against the approved specification. Depending on the formula and the analytical method, the result may be reported as elemental magnesium or on another defined magnesium-content basis. The release specification should state how that result is compared with the declared label amount.[4] In a multi-salt formula, laboratories often determine total magnesium rather than a separate elemental contribution from every salt.

Finished identity, where the specification requires it, confirms that the finished batch is consistent with the declared formula. It is not automatically a replay of every incoming salt-identity test.

Dosage-unit or fill-weight uniformity, where required by the approved specification or an applicable standard, evaluates individual capsules or tablets for weight or active-content consistency. Dietary-supplement practice commonly uses weight variation, in-process weight checks, and a finished assay; pharmaceutical content-uniformity of elemental magnesium on every unit is not an unconditional rule for every magnesium capsule or tablet.

Contaminant and microbiological testing on the finished product uses finished-product limits. Those limits may differ from the incoming drum limits.

The dosage form changes which of those fields are commercially decisive:

Capsules. Fill weight and blend uniformity usually sit next to assay. An underfilled or segregated capsule can miss the specification even when the incoming drum was within assay. Shell type (HPMC or gelatin) is a formula field; it is not a substitute for the release assay.

Tablets. Compression adds hardness, thickness, and friability where those attributes are on the specification. Weight variation remains a common uniformity tool. Disintegration or dissolution belongs on the file when the specification or the destination-market standard requires it — not as a default slogan on every magnesium tablet.

Powders and stick packs. Sachet or scoop fill, moisture-related physical behavior, and blend uniformity of a multi-component powder are the usual constraints. A drum assay does not confirm what a filled stick contains.

Liquids. Assay is typically reported per mL or per serving volume. Physical stability — settling, precipitation, resuspendability — and microbiology are often more decisive than they are in a dry capsule. Liposomal magnesium is a delivery system around a still-named salt; the salt identity and the magnesium-content basis still have to be on the specification.

Gummies add a cook step, so assay after the commercial cook is a different result from the incoming drum. Softgels are not the default path for dry magnesium salts unless an oil-compatible fill is on the formula.

What Each Magnesium Test Actually Proves

The same word on two COAs does not mean the same proof. Brands typically read each line as a job, a stage, and a document request.

A release COA that lists “assay: conforms” without a result, a method, or a specification limit tells the buyer very little. A COA that lists “magnesium 200 mg” without saying whether that is elemental magnesium, compound weight, raw-material basis, or finished-product basis is not yet a comparison document.

Why the Finished Result Can Differ From the Raw-Material COA

The incoming COA describes the starting material. It does not verify blend uniformity, material loss, fill-weight consistency, finished-batch sampling, or the composition of a multi-salt blend after those salts have been combined.

Blending. A drum is one material. A finished unit is that material mixed with excipients, other magnesium salts, and any companion ingredients. The magnesium content of one capsule depends on how well that blend was mixed, not only on the drum assay.

Segregation. Particle-size and density differences among magnesium salts, and between salts and excipients, can unmix a blend during transfer or filling. Incoming assay cannot see that.

Fill weight. An underfilled or overfilled capsule, tablet, sachet, or bottle carries a different amount of blend — and therefore a different amount of magnesium — than the target. Fill-weight control and, where specified, weight variation sit on the finished file.

Material loss and process variation. Dust loss, hold-up in equipment, and weighing or filling variation can move the batch away from the theoretical input. Processing does not create magnesium. It can, however, change how much of the weighed input is in the units that are sampled.

Sampling. A finished-product result is a result on the sample that was taken, prepared, and tested by the named method. Two laboratories using different methods, different sample preparations, or different reporting bases can disagree without either drum being “wrong.”

Multi-salt formulas. Several incoming COAs can all be in specification and still not describe the finished blend. The finished assay, where it reports total magnesium, confirms the combined magnesium content against the finished specification. It does not automatically reprint each salt’s incoming contribution.

Two manufacturers can buy the same grade from the same supplier and still release batches with different uniformity, fill-weight variation, and finished-assay outcomes, because the manufacturing and sampling files differ.

How Testing Changes for Multi-Salt Magnesium

A complex, triple, full-spectrum, or seven-magnesium blend is a composition, not a single magnesium number. Each salt still needs its own incoming identity and assay. The finished product is a different question: what did the manufactured blend test at, and on what basis?

Depending on the approved specification and the analytical strategy, finished testing may report total elemental magnesium rather than a separate elemental-magnesium contribution for every salt. If individual salt identity is commercially important — because the panel names each salt, because oxide share is part of the positioning, or because two complexes are being compared — that identity should be controlled in the raw-material and formulation specifications, not inferred from a single finished magnesium total. How that control is written into a per-salt specification is set out on the magnesium complex supplement manufacturer page.

The finished assay for a complex does not have to “split” every salt in the laboratory. Many methods cannot. What the buyer can request is documentation that makes the architecture visible.

A combined finished magnesium number without a per-salt specification is a total. Two complexes can share that total and still be different products. The label-level version of that problem — milligram line, salt weight, blend total — is the comparison in why two magnesium supplements with the same label are not comparable. Finished-product testing is how those architecture rows are evidenced after the formula is manufactured.

COA vs Specification vs Test Method vs Stability

Four documents are routinely treated as if they were one. They are not.

The COA is historical. It belongs to a lot or a finished batch. A generic certificate that does not identify the actual batch is not a batch COA.

The specification is the requirement. Without limits, a number on a COA has nothing to pass or fail against. Two factories can both “have a COA” and still be working to different strength ranges, different identity criteria, and different contaminant limits.

The test method is the measurement. Magnesium assay by titration and magnesium assay by ICP-OES are not automatically the same result. Sample preparation, as-is versus dried basis, elemental versus compound reporting, and finished-product versus raw-material basis all change the number. For how to read the document itself, see how to read a COA.

Stability data is time. A release COA is the batch at the time of testing. It is not evidence that the same attributes will remain within specification at expiry.

A buyer comparing two magnesium OEM quotes typically needs all four, not a single PDF labeled COA.

Magnesium COA Red Flags

Clarification is usually warranted when:

• only a raw-material COA is supplied against a finished-product quote;
• “magnesium assay” is shown without the analytical basis, reporting unit, or sample basis;
• the COA does not identify the magnesium salt or grade;
• specification limits are missing, so the result cannot be judged;
• the test method is not stated;
• a complex product reports only a total magnesium number when the commercial file requires confirmation of individual salt identity;
• the certificate is generic and does not identify the actual batch;
• finished-product testing is described in prose, but no finished-product specification is available;
• identity is inferred from the magnesium assay alone;
• two quotes are compared on matching 200 mg lines before method, specification basis, and elemental versus compound reporting are aligned.

None of those points automatically means the material is unfit. They mean the file is not yet comparable.

What to Request Before Comparing Magnesium OEM Quotes

The core procurement principle is the method, sitting beside the specification and the COA.

Two finished-product COAs can both report magnesium 200 mg and still not be comparable. Before those numbers are used as a price basis, brands typically confirm:

• the analytical method;
• the specification basis and acceptance range;
• the sample basis (raw material or finished product; as-is or dried);
• the reporting unit;
• whether the result is elemental magnesium or another defined magnesium-content basis;
• whether identity was tested as a separate field;
• for a complex, whether the finished result is total magnesium and how each salt is evidenced at incoming.

A practical request package is:

• the incoming raw-material COA for each magnesium salt, with identity, assay, method, and limits;
• the finished-product COA for the quoted SKU, with finished assay, method, basis, and the other release fields on that specification;
• the raw-material specification and the finished-product specification;
• the named test methods, not only the results;
• third-party verification when the destination market or the retail channel requires it — manufacturer QC, batch COA, and specification remain the default OEM path; independent laboratory testing (SGS, Eurofins, or equivalent) is risk-based and market-driven, not a universal extra COA on every SKU.

A single line — “magnesium 200 mg, please quote” — does not tell a factory which tests to run or which documents to return. Send two COAs with the specification sheets and the named methods when the quotes already disagree. Typical reply is within one business day; a project manager is assigned; NDA is available on request.

Stability and Shelf Life

A finished-product COA reports the batch at the time of release testing. A stability program is the file that supports how selected attributes behave over the declared shelf life, under the conditions written into that protocol.

For magnesium products, the attributes that usually matter are the specified magnesium-content line, physical characteristics that affect fill or appearance, and — for liquids — physical and microbiological behavior. Some magnesium salts are sensitive to moisture. Hygroscopicity can affect powder flow, fill consistency, caking, or other physical properties. Whether that is commercially relevant depends on the specific salt, hydrate form, particle size, formulation, packaging system, and storage conditions. It is not a standing rule that every citrate or every chloride grade will fail in every pack.

A powder or stick in a humid distribution lane, and a liquid magnesium SKU, are the formats where buyers most often ask for the stability protocol rather than the release COA alone. The release COA does not replace that file.

Frequently Asked Questions

If the incoming COA already shows the expected magnesium content, why test the finished product?

The incoming result describes the drum. The finished result describes the manufactured batch after weighing, blending, and filling. Blend uniformity, fill-weight variation, material loss, and sampling of the finished units are not visible on the incoming COA. U.S. dietary-supplement GMP treats finished-product specifications as a separate verification step from component testing.[1][2]

Can a laboratory report the correct magnesium number for the wrong salt?

Yes. Assay methods that quantify magnesium do not identify the salt. A citrate, an oxide, a malate, and a glycinate grade can all produce a magnesium result. Identity is a different test, governed by the specification for that grade. A buyer who treats a passing magnesium assay as proof of salt identity is reading the wrong field.

Does the finished-product assay have to match the Supplement Facts number as a single identical figure?

The finished result is evaluated against the approved specification and the applicable labeling requirements for the destination market.[4] The specification should define the analyte, the method, the basis, and the acceptance range. In a multi-salt product, the laboratory may report total magnesium rather than a separate elemental figure for each salt. “Matches the panel” is a specification-and-label question, not a guarantee that one elemental-magnesium number was measured in isolation and must equal the artwork line with no range.

Do all magnesium capsules and tablets require content uniformity of elemental magnesium?

No. Where required by the approved specification or an applicable standard, individual units may be evaluated for weight or for active-content consistency. Weight variation, in-process weight checks, and a finished assay are common dietary-supplement tools. Pharmaceutical dosage-unit content uniformity of elemental magnesium is not an automatic rule for every magnesium supplement capsule or tablet.

Two finished COAs both say magnesium 200 mg. What still has to match before the quotes are comparable?

Method, specification basis, sample basis, reporting unit, and whether 200 mg is elemental magnesium. A raw-material 200 mg line and a finished-product 200 mg line are different documents even when the digits match. A complex total of 200 mg is also a different architecture from 200 mg from a single named salt.

For a seven-salt blend, is a total magnesium assay enough?

It is enough for the question the total assay is designed to answer: combined magnesium content against the finished specification. It is not enough to prove each named salt is present in the declared proportion. Individual salt identity is typically evidenced by incoming COAs and the formulation specification. If per-salt contribution is commercially important, request that breakdown on the specification — do not infer it from the total.

Is third-party testing required on every magnesium SKU?

No. Manufacturer QC, the batch COA, and the specification are the usual OEM path. Independent laboratory verification is appropriate when the destination market, the retail channel, or the brand’s risk file requires it. Requiring a third-party certificate on every quote, without a market or channel reason, is not the same as requiring a complete manufacturer release file.

If the specification is missing, can the COA still be used to compare two quotes?

Only as a partial snapshot of one lot. A COA without limits cannot show whether the result passed, and a COA without a method cannot show whether two results were measured the same way. Specification, method, and batch COA together are the comparison set. The COA alone is a number looking for a requirement.

Related

• Magnesium Bisglycinate Supplements Manufacturing
• Magnesium Complex Supplement Manufacturer
• Magnesium Citrate Supplement Manufacturer
• Magnesium L-Threonate Supplement Manufacturer
• How to Read a COA

Technical and Regulatory References

1. U.S. Food and Drug Administration. 21 CFR 111.70 — What specifications must you establish? https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111/subpart-E/section-111.70
2. U.S. Food and Drug Administration. 21 CFR 111.75 — What must you do to determine whether specifications are met? https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111/subpart-E/section-111.75
3. U.S. Food and Drug Administration. Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements (21 CFR Part 111). https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111
4. U.S. Food and Drug Administration. 21 CFR 101.36 — Nutrition labeling of dietary supplements. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-101/section-101.36

Disclaimer: Wholesale and brand-manufacturing reference only. Not intended to diagnose, treat, cure, or prevent any disease. Dietary supplements are not drugs. Testing described here is a manufacturing and procurement reference — specific methods, limits, sampling plans, and stability protocols depend on the salt, the formula, the dosage form, the approved specification, and the destination market. A COA reports batch results against a specification; it is not a complete proof of product quality for every untested attribute. Brand owners remain responsible for finished-label compliance with local counsel.